이제는 완치까지도 바라본다?! 전이성 유방암 (HER2 양성, 저발현) 변화된 치료 방법
#breastcancer #metastaticcancer #cancer #her2 #her2positive Today's topic is breast cancer, the most common cancer among Korean women and the leading cause of death among women in their 40s and 50s. While breast cancer has a very high 10-year survival rate after surgery, at 84.8%, it's also a dangerous cancer, with survival rates dropping sharply if the cancer metastasizes to other organs. Today, we sat down with Professor Son Joo-hyuk of the Department of Oncology at Yonsei Cancer Center and Chairman of the Breast Cancer Subcommittee of the Korean Cancer Research Association to discuss breast cancer in detail. #Dong-A Ilbo #Lee Jin-han #MedicalReporter #MedicalInformation #MedicalKnowledge

▶︎
How Far Has Treatment for Metastatic Breast Cancer Gone? – Latest Treatment Strategies and Change...

▶︎
Beware, even after 10 years! Treatment for metastatic breast cancer, a difficult-to-cure conditio...

▶︎
허투양성유방암 (HER2 +)10분 요약 정리 | 유방채널 No.1 우리동네 유방이야기, 우유티비

▶︎
In this video, we summarize HER2-positive breast cancer, which grows the fastest but is the most ...

▶︎
Criteria for a Breast Cancer Cure? Is it safe to eat soy milk, soybeans, and raw fish during trea...
![We will share proven breast cancer management methods [Longevity with Disease]](https://i.ytimg.com/vi/EFpjLX5CEgc/hqdefault.jpg?sqp=-oaymwEjCNACELwBSFryq4qpAxUIARUAAAAAGAElAADIQj0AgKJDeAE=&rs=AOn4CLBkDqew7irTxFX1vHk38PlQWrYZ4g)
▶︎
We will share proven breast cancer management methods [Longevity with Disease]

▶︎
무엇이든 물어보세요 + HER2 유방암, 여전히 힘든 항암과 표적치료 / 강남세브란스병원 유방외과 안성귀

▶︎
"Stage 4 Breast Cancer! I was given 2 years to live, but I'm still here 10 years later" The 'thin...

▶︎
정밀의학 시대의 유방암: 호르몬과 표적치료 ep5.#유방암 호르몬 치료와 표적 치료 | #내가슴을부탁해

▶︎
분류 세부 기준까지 바꾼 '엔허투'… "HER2 저발현 환자의 새로운 선택지"

▶︎
"Tailored Treatment" A New Paradigm for Breast Cancer, the Leading Cancer in Women | Lee Jeong-eo...

▶︎
All About Breast Cancer Surgery I: Professor Jaehong Han, Breast Cancer Center, National Cancer C...

▶︎
유방암의 희망, 엔허투 급여 적용! 신약 항암효과는? | 삼성서울병원 김지연 교수

▶︎
"Breast Cancer Recurrence Rate Drastically Reduced by 30%!" Latest Treatments for Hormone-Positiv...
![전이성 유방암의 전신 치료 [서울대병원 혈액종양내과 임석아 교수]](https://i.ytimg.com/vi/pEODhiknOzg/hqdefault.jpg?sqp=-oaymwEjCNACELwBSFryq4qpAxUIARUAAAAAGAElAADIQj0AgKJDeAE=&rs=AOn4CLAIf9YOS5SeIVhCjZaxpqpA_EYNDg)
▶︎
전이성 유방암의 전신 치료 [서울대병원 혈액종양내과 임석아 교수]

▶︎
19년간 진료하면서 이만한 혹도 봤습니다 유방암은 정말 빨리 커집니다

▶︎
유방암 3기면 희망이 없다? 병기만 봐선 안 되는 이유
![[닥터스픽] 호르몬 양성 유방암 최신 치료 전략! HER2 저발현과 초저발현 | 삼성서울병원 신정훈 교수 & 이현우 교수](https://i.ytimg.com/vi/3olbdy6z75I/hqdefault.jpg?sqp=-oaymwEjCNACELwBSFryq4qpAxUIARUAAAAAGAElAADIQj0AgKJDeAE=&rs=AOn4CLAC8MZR-NxLHu2-KhIqS5rkP18zWg)
▶︎
[닥터스픽] 호르몬 양성 유방암 최신 치료 전략! HER2 저발현과 초저발현 | 삼성서울병원 신정훈 교수 & 이현우 교수

▶︎
기존 표적치료제보다 '뇌전이'에 효과적인 약은? HER2 양성 조기 유방암 치료제 효과 및 부작용!

▶︎
